Drugs Innovations

Lilly’s Retatrutide Shows Powerful Weight Loss Potential

Lilly sees retatrutide as part of a broader portfolio approach to obesity care alongside its existing therapies Zepbound (tirzepatide) and Foundayo (orforglipron).